Photon Qixin Fund Overview
Photon Qixin Fund General Information
Description
Photon Fund closed their Photon Qixin Fund at CNY 384 million on December 16, 2016. The fund focuses on investing into the cultural media, communications, and high-end manufacturing industries. The fund aims to invest in companies as they emerge from the start-up stage into growth stage.
Contact Information
Fund Manager's Location
- 2350 Mission College Boulevard
- Santa Clara, CA 95054
- United States
Photon Qixin Fund Investments (6)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Amplicore | 01-Mar-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Cardea | 12-Jan-2021 | Application Specific Semiconductors | Generating Revenue | |||
| Zhimeng Biopharma | 06-Nov-2020 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Nelumbo | 16-Apr-2020 | Other Materials | Generating Revenue | |||
| Valitor (Drug Discovery) | 21-Sep-2018 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| iYuedan | 27-Sep-2017 | Early Stage VC (Series B) | Information Services (B2C) | Generating Revenue |
Photon Qixin Fund Investment Strategy
Investments by Industry
Investments by Deal Type
Photon Qixin Fund Limited Partners (4)
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| China Commercial Foreign Trade Corporation | Current | 16-Dec-2016 | Original | ||
| Fujen Capital | Current | 16-Dec-2016 | Original | ||
| Xinhe Capital | Current | 16-Dec-2016 | Original | ||
| YTMF Capital | Fund of Funds | Current | 16-Dec-2016 | Original |
Photon Qixin Fund Team (2)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| James Lee | Managing Director | Santa Clara, CA | |||
| Zhenlin Li | Partner | Santa Clara, CA |
Photon Qixin Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Photon Qixin Fund Benchmark (451)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Venture Capital Investment Partners 2014 | |||||
| H. Barton Venture Select II | |||||
| ShangBay Capital | |||||
| Cornelius Capital Venture Fund I | |||||
| Fenway Summer Ventures | |||||
| MEP Associates V | 31-Mar-2020 | ||||
| IA Venture Strategies Fund III | 31-Mar-2024 | ||||
| Firebolt Ventures Fund | |||||
| ClearSky Surry | |||||
| Harrison Metal Capital IV |
Photon Qixin Fund FAQs
-
What is Photon Qixin Fund?
Photon Fund closed their Photon Qixin Fund at CNY 384 million on December 16, 2016.
-
Who manages Photon Qixin Fund?
Photon Qixin Fund is managed by Photon Fund.
-
Where is Photon Qixin Fund domiciled?
Photon Qixin Fund is domiciled in China.
-
What is Photon Qixin Fund's size?
Photon Qixin Fund has a size of .
-
What type of fund is Photon Qixin Fund?
The fund type of Photon Qixin Fund is Venture.
-
What is the status of Photon Qixin Fund?
Photon Qixin Fund is closed.
-
What has Photon Qixin Fund invested in?
Photon Qixin Fund has made numerous investments in companies like Amplicore, Cardea, and Zhimeng Biopharma within the Drug Discovery and Application Specific Semiconductors industries.
-
What has Photon Qixin Fund invested in recently?
Photon Qixin Fund's latest investment was on 01-Mar-2021 in Amplicore, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
